HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by NewEdge Wealth LLC

NewEdge Wealth LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,173 shares of the company's stock after selling 1,515 shares during the quarter. NewEdge Wealth LLC's holdings in HCA Healthcare were worth $2,153,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $39,000. Activest Wealth Management raised its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Pinnacle Bancorp Inc. raised its position in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Eastern Bank purchased a new position in shares of HCA Healthcare in the fourth quarter worth $62,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

NYSE HCA traded up $4.81 on Monday, hitting $311.11. The company had a trading volume of 1,413,615 shares, compared to its average volume of 1,731,940. The company has a market capitalization of $77.26 billion, a PE ratio of 14.16, a PEG ratio of 1.10 and a beta of 1.64. The company's fifty day moving average price is $315.30 and its 200-day moving average price is $348.80. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company posted $5.90 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.93%. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is currently 13.11%.

Analysts Set New Price Targets

HCA has been the subject of a number of research analyst reports. Barclays reduced their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Wells Fargo & Company cut shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and reduced their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.